Barclays’s Alumis Inc ALMS Stock Holding History

Barclays’s Portfolio ALMS Stock Details ALMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,300	Closed	-$81K	–	5533
2025 Q4	$81K	Buy	+8,300	New	+$57.9K	﹤0.01%	4632

Other funds holding ALMS

ACMC

AyurMaya Capital Management Company Portsmouth, New Hampshire $426M AUM 838% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Barclays's ALMS Position: Q2 2026 in Review

Barclays increased its Alumis Inc (ALMS) stake by 23% in Q2 2026, buying an estimated $1.19M and bringing the position to 273,716 shares worth $7.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

Barclays first reported a position in ALMS in Q3 2024 and has held it in 8 quarters since. 198 funds tracked by Wall St. Rank hold ALMS as of Q2 2026.

Barclays held 273,716 shares of Alumis Inc worth $7.7M as of Q2 2026.
Barclays bought 51,058 Alumis Inc shares in Q2 2026, an estimated $1.19M.
Alumis Inc made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1619 holding.
Barclays first reported a position in Alumis Inc in Q3 2024 and has held it in 8 quarters since.
198 funds tracked by Wall St. Rank held Alumis Inc as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.